Search results
Results from the WOW.Com Content Network
The Papanicolaou test (abbreviated as Pap test, also known as Pap smear (AE), [1] cervical smear (BE), cervical screening (BE), [2] or smear test (BE)) is a method of cervical screening used to detect potentially precancerous and cancerous processes in the cervix (opening of the uterus or womb) or, more rarely, anus (in both men and women). [3]
Papanicolaou stain (also Papanicolaou's stain and Pap stain) is a multichromatic (multicolored) cytological staining technique developed by George Papanicolaou in 1942. [ 1 ] [ 2 ] [ 3 ] The Papanicolaou stain is one of the most widely used stains in cytology , [ 1 ] where it is used to aid pathologists in making a diagnosis.
Due to cost, pain, or other factors, many women avoid traditional Pap smears that test for HPV and cervical cancer—experts say these new self-collection tests could help close that gap.
Cervical cancer screening is a medical screening test designed to identify risk of cervical cancer. Cervical screening may involve looking for viral DNA, and/or to identify abnormal, potentially precancerous cells within the cervix as well as cells that have progressed to early stages of cervical cancer. [1][2] One goal of cervical screening is ...
Korin Miller. June 14, 2024 at 11:06 AM. A new study finds that cervical cancer screenings have dropped. (Getty Images) (SDI Productions via Getty Images) While cervical cancer was once one of the ...
The Pap test is still widely used as a means of early cancer detection and is estimated to have reduced fatalities caused by cancer of the reproductive systems in women by half. [10] By some accounts, the pap test is considered the most significant advance in the control of cancer in the 20th century.
The Bethesda system (TBS), officially called The Bethesda System for Reporting Cervical Cytology, is a system for reporting cervical or vaginal cytologic diagnoses, [1] used for reporting Pap smear results. It was introduced in 1988 [2] and revised in 1991, [3] 2001, [1][4][5] and 2014. [6] The name comes from the location (Bethesda, Maryland ...
The test can be used to complement a pap smear in screening of cervical cancer. A negative speculoscopy, along with a negative pap smear provides greater assurance of absence of disease. [citation needed] It was developed in 1988. [1] It was FDA approved as an add-on to Pap smear screening in 1995. [1]